Logo image of AMWL

AMERICAN WELL CORP-CLASS A (AMWL) Stock Fundamental Analysis

NYSE:AMWL - US03044L2043 - Common Stock

6.97 USD
+0.02 (+0.29%)
Last: 8/28/2025, 8:04:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AMWL. AMWL was compared to 35 industry peers in the Health Care Technology industry. AMWL has a great financial health rating, but its profitability evaluates not so good. AMWL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AMWL has reported negative net income.
AMWL had a negative operating cash flow in the past year.
In the past 5 years AMWL always reported negative net income.
In the past 5 years AMWL always reported negative operating cash flow.
AMWL Yearly Net Income VS EBIT VS OCF VS FCFAMWL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

With a Return On Assets value of -32.04%, AMWL is not doing good in the industry: 62.86% of the companies in the same industry are doing better.
With a Return On Equity value of -44.06%, AMWL perfoms like the industry average, outperforming 48.57% of the companies in the same industry.
Industry RankSector Rank
ROA -32.04%
ROE -44.06%
ROIC N/A
ROA(3y)-61.48%
ROA(5y)-42.59%
ROE(3y)-79.72%
ROE(5y)-54.34%
ROIC(3y)N/A
ROIC(5y)N/A
AMWL Yearly ROA, ROE, ROICAMWL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -50 -100

1.3 Margins

With a Gross Margin value of 49.44%, AMWL perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
AMWL's Gross Margin has declined in the last couple of years.
AMWL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.79%
GM growth 5Y-3.32%
AMWL Yearly Profit, Operating, Gross MarginsAMWL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

7

2. Health

2.1 Basic Checks

AMWL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMWL has been reduced compared to 1 year ago.
The number of shares outstanding for AMWL has been reduced compared to 5 years ago.
AMWL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AMWL Yearly Shares OutstandingAMWL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
AMWL Yearly Total Debt VS Total AssetsAMWL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

Based on the Altman-Z score of -6.35, we must say that AMWL is in the distress zone and has some risk of bankruptcy.
AMWL has a Altman-Z score of -6.35. This is amonst the worse of the industry: AMWL underperforms 85.71% of its industry peers.
AMWL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -6.35
ROIC/WACCN/A
WACC9.97%
AMWL Yearly LT Debt VS Equity VS FCFAMWL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

AMWL has a Current Ratio of 3.29. This indicates that AMWL is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AMWL (3.29) is better than 71.43% of its industry peers.
A Quick Ratio of 3.27 indicates that AMWL has no problem at all paying its short term obligations.
AMWL has a better Quick ratio (3.27) than 74.29% of its industry peers.
Industry RankSector Rank
Current Ratio 3.29
Quick Ratio 3.27
AMWL Yearly Current Assets VS Current LiabilitesAMWL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

AMWL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.99%, which is quite impressive.
AMWL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.84%.
The Revenue has been growing by 11.30% on average over the past years. This is quite good.
EPS 1Y (TTM)58.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.1%
Revenue 1Y (TTM)5.84%
Revenue growth 3Y0.21%
Revenue growth 5Y11.3%
Sales Q2Q%12.91%

3.2 Future

The Earnings Per Share is expected to grow by 12.97% on average over the next years. This is quite good.
AMWL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.64% yearly.
EPS Next Y53.97%
EPS Next 2Y27.98%
EPS Next 3Y20.78%
EPS Next 5Y12.97%
Revenue Next Year-0.46%
Revenue Next 2Y1.44%
Revenue Next 3Y5.74%
Revenue Next 5Y2.64%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMWL Yearly Revenue VS EstimatesAMWL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M
AMWL Yearly EPS VS EstimatesAMWL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 -10 -20 -30 -40

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AMWL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMWL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMWL Price Earnings VS Forward Price EarningsAMWL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMWL Per share dataAMWL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as AMWL's earnings are expected to grow with 20.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.98%
EPS Next 3Y20.78%

More info and screens

0

5. Dividend

5.1 Amount

AMWL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN WELL CORP-CLASS A

NYSE:AMWL (8/28/2025, 8:04:00 PM)

6.97

+0.02 (+0.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners43.19%
Inst Owner Change0%
Ins Owners3.91%
Ins Owner Change2.77%
Market Cap112.57M
Analysts71.43
Price Target10.05 (44.19%)
Short Float %1.36%
Short Ratio3.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.69%
Min EPS beat(2)30.19%
Max EPS beat(2)31.2%
EPS beat(4)4
Avg EPS beat(4)21.44%
Min EPS beat(4)7.21%
Max EPS beat(4)31.2%
EPS beat(8)6
Avg EPS beat(8)-4.17%
EPS beat(12)8
Avg EPS beat(12)-6.05%
EPS beat(16)11
Avg EPS beat(16)-1.57%
Revenue beat(2)2
Avg Revenue beat(2)8.78%
Min Revenue beat(2)8.64%
Max Revenue beat(2)8.93%
Revenue beat(4)3
Avg Revenue beat(4)4.18%
Min Revenue beat(4)-5.41%
Max Revenue beat(4)8.93%
Revenue beat(8)3
Avg Revenue beat(8)0.98%
Revenue beat(12)3
Avg Revenue beat(12)-0.27%
Revenue beat(16)4
Avg Revenue beat(16)-0.68%
PT rev (1m)-4.17%
PT rev (3m)-7.23%
EPS NQ rev (1m)-4.68%
EPS NQ rev (3m)6.25%
EPS NY rev (1m)2.3%
EPS NY rev (3m)23.61%
Revenue NQ rev (1m)-12.18%
Revenue NQ rev (3m)-12.38%
Revenue NY rev (1m)-2.87%
Revenue NY rev (3m)-2.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.42
P/FCF N/A
P/OCF N/A
P/B 0.4
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)-8.76
EYN/A
EPS(NY)-5.07
Fwd EYN/A
FCF(TTM)-5.13
FCFYN/A
OCF(TTM)-4.68
OCFYN/A
SpS16.7
BVpS17.5
TBVpS12.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.04%
ROE -44.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.44%
FCFM N/A
ROA(3y)-61.48%
ROA(5y)-42.59%
ROE(3y)-79.72%
ROE(5y)-54.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.79%
GM growth 5Y-3.32%
F-Score6
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.99%
Cap/Sales 2.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.29
Quick Ratio 3.27
Altman-Z -6.35
F-Score6
WACC9.97%
ROIC/WACCN/A
Cap/Depr(3y)44.83%
Cap/Depr(5y)34.13%
Cap/Sales(3y)5.21%
Cap/Sales(5y)3.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.1%
EPS Next Y53.97%
EPS Next 2Y27.98%
EPS Next 3Y20.78%
EPS Next 5Y12.97%
Revenue 1Y (TTM)5.84%
Revenue growth 3Y0.21%
Revenue growth 5Y11.3%
Sales Q2Q%12.91%
Revenue Next Year-0.46%
Revenue Next 2Y1.44%
Revenue Next 3Y5.74%
Revenue Next 5Y2.64%
EBIT growth 1Y48.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year77.46%
EBIT Next 3Y26.05%
EBIT Next 5Y15.81%
FCF growth 1Y54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.43%
OCF growth 3YN/A
OCF growth 5YN/A